Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Oramed Pharmaceuticals Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
ORMP
Nasdaq
2834
www.oramed.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals And 2 Other US Penny Stocks To Watch
- Feb 12th, 2025 12:11 am
Oramed Announces Transformative Joint Venture to Accelerate Development and Commercialization of Oral Insulin
- Feb 11th, 2025 2:15 pm
3 US Penny Stocks With Market Caps Above $40M
- Dec 4th, 2024 8:12 pm
ORMP: Preparations for New Phase 3 Trial Advance, While ORMP Leverages Balance Sheet Through Recent Agreements
- Dec 2nd, 2024 3:09 pm
US Penny Stocks To Watch: 3 Picks With Market Caps Over $40M
- Nov 5th, 2024 8:04 pm
Scilex Holding Starts $50 Million Registered Direct Offering of Convertible Notes
- Oct 7th, 2024 2:50 pm
Oramed Pharmaceuticals Announces Restructuring of Scilex Holding Company Debt
- Oct 7th, 2024 2:00 pm
ORMP: Balance Sheet Strong, Potential Benefits of Investments, JVs, Buybacks
- Aug 29th, 2024 3:29 pm
Oramed: Q2 Earnings Snapshot
- Aug 15th, 2024 9:12 am
3 Micro-Cap Moonshots for Fearless Investors
- Jul 8th, 2024 7:07 pm
Oramed Letter to Shareholders
- Jun 26th, 2024 1:05 pm
Oramed Pharmaceuticals Inc. Announces the Buy-Back of its Common Stock
- Jun 26th, 2024 1:00 pm
ORMP: Moving Oral Delivery Platform Forward, + Potential to Generate Royalties
- May 29th, 2024 2:00 pm
Oramed Pharmaceuticals First Quarter 2024 Earnings: EPS: US$0.038 (vs US$0.085 loss in 1Q 2023)
- May 12th, 2024 1:36 pm
Scilex Holding Company Announces Repayment in Full of the Remaining Balance of Convertible Debentures and Early Payment of the Senior Secured Promissory Note, Paving the Way for Future Growth and Innovation
- Mar 19th, 2024 1:00 pm
Oramed Pharmaceuticals Full Year 2023 Earnings: Beats Expectations
- Mar 9th, 2024 2:32 pm
Scroll